AIM: To conduct a meta-analysis evaluating the association between the peripheral blood
neutrophil to lymphocyte ratio (NLR) and the outcome of patients with pancreatic cancer …

Several studies were carried out to explore the prognostic role of neutrophil-to-lymphocyte
ratio (NLR) in pancreatic cancer, however, with contradictory results. The objectives of this …

Background: Positive findings from the phase III MPACT trial led to the regulatory approval of
nab-paclitaxel plus gemcitabine as a treatment option for patients with metastatic pancreatic …

An accurate, time efficient, and inexpensive prognostic indicator is needed to reduce cost
and assist with clinical decision making for cancer management. The neutrophil-to …

Background Recently, several preoperative proinflammatory markers and nutritional factors
such as neutrophil-to-lymphocyte ratio (NLR) and prognostic nutrition index (PNI) have been …

Recent studies defined a potentially important role of the microbiome in modulating
pancreatic ductal adenocarcinoma (PDAC) and responses to therapies. We hypothesized …

The relationship between the neutrophil-to-lymphocyte ratio (NLR) and tumours as a
prognostic factor has been reported in many studies. In this meta-analysis, we evaluated the …

Background/Objectives. This meta‐analysis is aimed at investigating the prognostic roles of
the inflammatory markers neutrophil‐to‐lymphocyte ratio (NLR) and platelet‐to‐lymphocyte …

During our research on circulating tumor cells (CTCs) derived from tumor-adjacent vessels
in pancreatic ductal adenocarcinoma (PDAC), we found that CTCs are sometimes …

AIM: To evaluate the value of systemic inflammation-based markers as prognostic factors for
advanced pancreatic cancer (PC). METHODS: Data from 82 patients who underwent …